Gilde healthcare sells LAVA Therapeutics (LVTX) shares for $718k
NeutralFinancial Markets

Gilde Healthcare has sold its shares in LAVA Therapeutics for $718,000. This transaction highlights the ongoing changes in the healthcare investment landscape, as firms reassess their portfolios and strategies. The sale may impact LAVA's market position and investor sentiment, but it also reflects Gilde's strategic decisions in managing its investments.
— Curated by the World Pulse Now AI Editorial System